Multi-omics Analysis to Screen Potential Therapeutic Biomarkers for Anti-cancer Compounds

Overview

Journal Heliyon

Specialty Social Sciences

Date 2022 Sep 12

PMID 36091949

Authors

Ruxue Li

Wuai Zhou

Affiliations

Soon will be listed here.

Abstract

Discover potential biomarkers of the response for anti-cancer therapies, including traditional Chinese medicine (TCM), is a critical but much different task in the field of cancer research. Based on accumulated data and sophisticated methods, multi-omics analysis provides a feasible strategy for the discovery of potential therapeutic biomarkers. Here, we screened the potential therapeutic biomarkers for anti-cancer compounds in TCM through multi-omics data analysis. Firstly, compounds in TCM were collected from the public databases. Then, the molecules that those compounds can intervene on cell lines were carefully filtered out from existing drug bioactivity datasets. Finally, multi-omics analysis including gene mutation analysis, differential expression gene analysis, copy number variation analysis and clinical survival analysis for pan-cancer were conducted to screen potential therapeutic biomarkers for compounds in TCM. 13 molecules of compounds in TCM namely ERBB2, MYC, FLT4, TEK, GLI1, TOP2A, PDE10A, SLC6A3, GPR55, TERT, EGFR, KCNA3 and HDAC4 are differentially expressed, high frequently mutated, obtain high copy number variation rate and also significant in survival, are considered as the potential therapeutic biomarkers.

Citing Articles

Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers.

Tenchov R, Sapra A, Sasso J, Ralhan K, Tummala A, Azoulay N ACS Pharmacol Transl Sci. 2024; 7(3):586-613.

PMID: 38481702 PMC: 10928905. DOI: 10.1021/acsptsci.3c00346.

Anti-Tumor Secondary Metabolites Originating from Fungi in the South China Sea's Mangrove Ecosystem.

Luo Y, Luo X, Zhang T, Li S, Liu S, Ma Y Bioengineering (Basel). 2022; 9(12).

PMID: 36550982 PMC: 9774444. DOI: 10.3390/bioengineering9120776.

References

Bento A, Gaulton A, Hersey A, Bellis L, Chambers J, Davies M . The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2013; 42(Database issue):D1083-90. PMC: 3965067. DOI: 10.1093/nar/gkt1031. View

Zheng J, Wu M, Wang H, Li S, Wang X, Li Y . Network Pharmacology to Unveil the Biological Basis of Health-Strengthening Herbal Medicine in Cancer Treatment. Cancers (Basel). 2018; 10(11). PMC: 6266222. DOI: 10.3390/cancers10110461. View

Wang C, Bai X, Wang C . Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med. 2014; 42(3):543-59. DOI: 10.1142/S0192415X14500359. View

Barrett T, Troup D, Wilhite S, Ledoux P, Evangelista C, Kim I . NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res. 2010; 39(Database issue):D1005-10. PMC: 3013736. DOI: 10.1093/nar/gkq1184. View

Guo Y, Bao C, Ma D, Cao Y, Li Y, Xie Z . Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells. ACS Synth Biol. 2019; 8(3):482-490. DOI: 10.1021/acssynbio.8b00237. View

Huang C, Chan C, Chou I, Lien C, Hung H, Lee M . Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells. J Nutr Biochem. 2013; 24(9):1596-603. DOI: 10.1016/j.jnutbio.2013.01.010. View

Yang W, Soares J, Greninger P, Edelman E, Lightfoot H, Forbes S . Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012; 41(Database issue):D955-61. PMC: 3531057. DOI: 10.1093/nar/gks1111. View

Colaprico A, C Silva T, Olsen C, Garofano L, Cava C, Garolini D . TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2015; 44(8):e71. PMC: 4856967. DOI: 10.1093/nar/gkv1507. View

Ye H, Ye L, Kang H, Zhang D, Tao L, Tang K . HIT: linking herbal active ingredients to targets. Nucleic Acids Res. 2010; 39(Database issue):D1055-9. PMC: 3013727. DOI: 10.1093/nar/gkq1165. View

10.

Garnett M, Edelman E, Heidorn S, Greenman C, Dastur A, Lau K . Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012; 483(7391):570-5. PMC: 3349233. DOI: 10.1038/nature11005. View

11.

Li X, Zhang J, Huang J, Ma A, Yang J, Li W . A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol. 2013; 62(12):1065-1072. DOI: 10.1016/j.jacc.2013.05.035. View

12.

Wang T, Shao W, Huang Z, Tang H, Zhang J, Ding Z . MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun. 2021; 12(1):3445. PMC: 8187432. DOI: 10.1038/s41467-021-23774-w. View

13.

Mounir M, Lucchetta M, C Silva T, Olsen C, Bontempi G, Chen X . New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019; 15(3):e1006701. PMC: 6420023. DOI: 10.1371/journal.pcbi.1006701. View

14.

Wu M, Lu P, Shi L, Li S . Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis. Oncotarget. 2015; 6(35):38283-95. PMC: 4741999. DOI: 10.18632/oncotarget.5711. View

15.

Amjad E, Asnaashari S, Sokouti B, Dastmalchi S . Impact of Gene Biomarker Discovery Tools Based on Protein-Protein Interaction and Machine Learning on Performance of Artificial Intelligence Models in Predicting Clinical Stages of Breast Cancer. Interdiscip Sci. 2020; 12(4):476-486. DOI: 10.1007/s12539-020-00390-8. View

16.

Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling G . Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol. 2020; 16(5):247-264. DOI: 10.1038/s41582-020-0350-6. View

17.

Zhong L, Cheng C, Kun W, Dai L, Hu D, Ning Z . Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2018; 17(7):1303-1310.e18. DOI: 10.1016/j.cgh.2018.04.005. View

18.

Deng G, Cassileth B . Complementary or alternative medicine in cancer care-myths and realities. Nat Rev Clin Oncol. 2013; 10(11):656-64. DOI: 10.1038/nrclinonc.2013.125. View

19.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

20.

Cheung F . TCM: Made in China. Nature. 2011; 480(7378):S82-3. DOI: 10.1038/480S82a. View